The ITGB6-EGFR-interaction is abolished upon ITGB2 or mutITGB2 transfection, suggesting a functional switching of a complex containing ITGB6-EGFR in NSCLC to a complex containing ITGB2-EGFR in SCLC. Here, ITGB2 is linked to non-small cell lung carcinoma.